A recent 2025 study in Nature revealed that scientists employed deep learning and molecular docking to pinpoint natural compounds, notably Forsythoside A, as potent LOXL2 inhibitors. This breakthrough offers a glimpse into advanced drug screening methods that could reshape cancer therapy.